| Pregnancy |
1 |
1 |
| Cardiovascular Risk Management |
0 |
0.98 |
| Infertility Female |
0 |
0.9 |
| Polycystic Ovary Syndrome |
0 |
0.99 |
| Heart |
0 |
0.51 |
| Heart Failure (HF) |
0 |
0.48 |
| Birth |
0 |
0.97 |
| Blood |
0 |
0.13 |
| Cardiovascular disease |
0 |
0.13 |
| Hospital |
0 |
0.96 |
| Infertility |
0 |
0.13 |
| Thrombus |
0 |
0.13 |
| Lipids Management |
0 |
0.12 |
| Atherosclerosis |
0 |
0.11 |
| Coronary Artery Calcification |
0 |
0.09 |
| Preeclampsia |
0 |
0.09 |
| Reproductive Endocrinology |
0 |
0.09 |
| Artery |
0 |
0.06 |
| Board Certification |
0 |
0.06 |
| Calcaneal |
0 |
0.06 |
| CRISPR |
0 |
0.06 |
| Eclampsia |
0 |
0.06 |
| Endocrinology |
0 |
0.06 |
| Exercise |
0 |
0.06 |
| Fertility |
0 |
0.06 |
| Genomic Medicine |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Inpatient Care |
0 |
0.06 |
| Irregular Menses |
0 |
0.06 |
| Meta-Analysis |
0 |
0.06 |
| Ovary |
0 |
0.06 |
| Preventive Screening |
0 |
0.06 |
| Primary Care |
0 |
0.06 |
| Statins |
0 |
0.06 |
| Thromboembolism |
0 |
0.06 |